Physician profile
Robert J Bos
NPI 1134295181
$2,170.31
in general payments reported to CMS, 2019-2025
20 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $109 · 2021: $138 · 2022: $458 · 2023: $453 · 2024: $400 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,217.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $580.11 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Idorsia Pharmaceuticals US INC | $316.51 | 2022-2024 | Quviviq |
| Glaxosmithkline, LLC. | $308.53 | 2020-2025 | Trelegy Ellipta |
| Bausch Health US, LLC | $277.62 | 2022-2025 | Aplenzin, Wellbutrin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $172.46 | 2021-2024 | Xifaxan |
| Lilly USA, LLC | $90.29 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $88.42 | 2024-2025 | Ozempic, Rybelsus |
| Mylan Specialty L.P. | $40.18 | 2019 | |
| Genentech USA, INC. | $33.86 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $33.42 | 2024 | |
| Biogen, INC. | $31.46 | 2021 | |
| Gilead Sciences, INC. | $30.52 | 2019 | |
| Inspire Medical Systems, INC. | $28.86 | 2024 | Inspire |
| Biohaven Pharmaceutical Holding Company Ltd. | $26.42 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $24.05 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $22.89 | 2022 | |
| Exact Sciences Corporation | $18.15 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $17.11 | 2021 | |
| Eisai INC. | $16.45 | 2020 | |
| Allergan, INC. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.